Skip to main content
. 2013 Sep 12;8(9):e73320. doi: 10.1371/journal.pone.0073320

Figure 2. Cumulative proportion of patients' survival at 30 days and 6 months according to mtDNA haplogroup JT versus no JT.

Figure 2